• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ovarian cancer screening.

作者信息

Mackey S E, Creasman W T

机构信息

Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston 29425.

出版信息

J Clin Oncol. 1995 Mar;13(3):783-93. doi: 10.1200/JCO.1995.13.3.783.

DOI:10.1200/JCO.1995.13.3.783
PMID:7884436
Abstract

PURPOSE

To review potential screening tools of early ovarian cancer and the associated risk factors for the development of ovarian carcinoma.

DESIGN AND RESULTS

A review of pertinent literature was conducted, restricted to English-language published reports, book chapters, and articles. The value of serum tumor markers, particularly CA 125, ultrasound, transabdominal and transvaginal ultrasonography, and transvaginal color Doppler imaging as screening tools for ovarian cancer was assessed.

CONCLUSION

Based on the literature, a large-scale long-term study that compares the mortality rates of a screened versus unscreened patient population is required before the efficacy of any screening method can be determined definitively.

摘要

相似文献

1
Ovarian cancer screening.
J Clin Oncol. 1995 Mar;13(3):783-93. doi: 10.1200/JCO.1995.13.3.783.
2
Update on ovarian cancer screening.卵巢癌筛查的最新进展。
Curr Opin Obstet Gynecol. 2007 Feb;19(1):22-6. doi: 10.1097/GCO.0b013e328011ec99.
3
[Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].[市立医院为女性提供的作为预防措施的卵巢癌早期检测项目]
Wiad Lek. 2004;57 Suppl 1:43-7.
4
Evaluation of transvaginal color Doppler sonography, transvaginal sonography and CA 125 for prediction of ovarian malignancy.经阴道彩色多普勒超声、经阴道超声及CA 125对卵巢恶性肿瘤预测价值的评估。
Int J Gynaecol Obstet. 1994 Jul;46(1):39-43. doi: 10.1016/0020-7292(94)90307-7.
5
Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.利用彩色和脉冲多普勒超声以及血清CA - 125、CA - 19.9、CA - 72.4和血管内皮生长因子测量对良性和恶性卵巢肿瘤血管生成的研究。
Ann Univ Mariae Curie Sklodowska Med. 2002;57(1):113-31.
6
Preoperative assessment of ovarian tumors by CA 125 measurement and transvaginal color Doppler ultrasound.通过CA 125检测和经阴道彩色多普勒超声对卵巢肿瘤进行术前评估。
Acta Med Croatica. 2002;56(1):3-10.
7
Current status of screening for ovarian cancer.
Gynecol Oncol. 1994 Dec;55(3 Pt 2):S34-7. doi: 10.1006/gyno.1994.1338.
8
[Sonography of malignant ovarian tumors].[恶性卵巢肿瘤的超声检查]
MMW Fortschr Med. 2005 Oct 27;147(43):26-8, 30.
9
Screening for ovarian cancer: a systematic review.卵巢癌筛查:一项系统评价
Health Technol Assess. 1998;2(2):i-iv, 1-84.
10
Population screening and early detection of ovarian cancer in asymptomatic women.无症状女性卵巢癌的人群筛查与早期检测
Aust N Z J Obstet Gynaecol. 2009 Oct;49(5):448-50. doi: 10.1111/j.1479-828X.2009.01064.x.

引用本文的文献

1
Mucins in ovarian cancer diagnosis and therapy.黏液蛋白在卵巢癌诊断与治疗中的作用。
J Ovarian Res. 2009 Dec 24;2:21. doi: 10.1186/1757-2215-2-21.
2
Characterisation of human kallikrein 6/protease M expression in ovarian cancer.人组织激肽释放酶6/蛋白酶M在卵巢癌中的表达特征
Br J Cancer. 2004 Aug 16;91(4):725-31. doi: 10.1038/sj.bjc.6602041.
3
Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer.基于蛋白质组学鉴定触珠蛋白-1前体作为卵巢癌一种新型循环生物标志物。
Br J Cancer. 2004 Jul 5;91(1):129-40. doi: 10.1038/sj.bjc.6601882.
4
Forth nightly review: hereditary ovarian carcinoma.第四次夜间查房:遗传性卵巢癌
BMJ. 1999 Mar 20;318(7186):786-9. doi: 10.1136/bmj.318.7186.786.